Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)
Brazil
· Delayed Price · Currency is BRL 1.550
0.00 (0.00%)
Apr 28, 2026, 5:07 PM GMT-3
BVMF:ONCO3 Income Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 5,739 | 6,227 | 5,489 | 4,088 | 2,702 | Upgrade
|
| Revenue Growth (YoY) | -7.83% | 13.45% | 34.26% | 51.30% | 32.77% | Upgrade
|
| Cost of Revenue | 3,953 | 4,167 | 3,560 | 2,636 | 1,833 | Upgrade
|
| Gross Profit | 1,786 | 2,060 | 1,929 | 1,452 | 868.79 | Upgrade
|
| Selling, General & Admin | 1,361 | 1,397 | 1,172 | 980.82 | 688.05 | Upgrade
|
| Other Operating Expenses | 1,790 | -20.37 | -13.16 | 0.19 | 3.53 | Upgrade
|
| Operating Expenses | 3,152 | 1,376 | 1,159 | 981.01 | 691.58 | Upgrade
|
| Operating Income | -1,365 | 684.02 | 769.67 | 471.1 | 177.22 | Upgrade
|
| Interest Expense | -648.12 | -728.16 | -563.39 | -490.11 | -154.36 | Upgrade
|
| Interest & Investment Income | 158.49 | 143.44 | 105.54 | 141.08 | 54.41 | Upgrade
|
| Earnings From Equity Investments | 0.18 | -7.9 | -11.65 | -0.54 | - | Upgrade
|
| Currency Exchange Gain (Loss) | 14.68 | -29 | 7.92 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -609.99 | 91.58 | 8.87 | - | -10.98 | Upgrade
|
| EBT Excluding Unusual Items | -2,450 | 153.98 | 316.95 | 121.54 | 66.29 | Upgrade
|
| Gain (Loss) on Sale of Investments | -67.11 | - | - | - | - | Upgrade
|
| Asset Writedown | -625.33 | -796.07 | - | - | - | Upgrade
|
| Legal Settlements | -20.16 | -14.77 | -14.43 | - | -3.95 | Upgrade
|
| Pretax Income | -3,163 | -656.86 | 302.52 | 121.54 | 62.34 | Upgrade
|
| Income Tax Expense | 508.47 | 60.57 | -10.04 | 7.77 | 84.75 | Upgrade
|
| Earnings From Continuing Operations | -3,671 | -717.43 | 312.56 | 113.77 | -22.42 | Upgrade
|
| Minority Interest in Earnings | 47.32 | 71.24 | -88.94 | -67.51 | -24.48 | Upgrade
|
| Net Income | -3,624 | -646.19 | 223.62 | 46.26 | -46.9 | Upgrade
|
| Net Income to Common | -3,624 | -646.19 | 223.62 | 46.26 | -46.9 | Upgrade
|
| Net Income Growth | - | - | 383.39% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 867 | 616 | 524 | 480 | 412 | Upgrade
|
| Shares Outstanding (Diluted) | 867 | 616 | 536 | 532 | 412 | Upgrade
|
| Shares Change (YoY) | 40.59% | 15.09% | 0.72% | 28.93% | 2.65% | Upgrade
|
| EPS (Basic) | -4.18 | -1.05 | 0.43 | 0.10 | -0.11 | Upgrade
|
| EPS (Diluted) | -4.18 | -1.05 | 0.42 | 0.09 | -0.11 | Upgrade
|
| EPS Growth | - | - | 379.95% | - | - | Upgrade
|
| Free Cash Flow | -286.75 | -399.1 | -363.26 | -571.82 | -211.23 | Upgrade
|
| Free Cash Flow Per Share | -0.33 | -0.65 | -0.68 | -1.07 | -0.51 | Upgrade
|
| Gross Margin | 31.12% | 33.09% | 35.14% | 35.52% | 32.15% | Upgrade
|
| Operating Margin | -23.79% | 10.98% | 14.02% | 11.52% | 6.56% | Upgrade
|
| Profit Margin | -63.14% | -10.38% | 4.07% | 1.13% | -1.74% | Upgrade
|
| Free Cash Flow Margin | -5.00% | -6.41% | -6.62% | -13.99% | -7.82% | Upgrade
|
| EBITDA | -1,192 | 874.68 | 931.27 | 646.25 | 270.2 | Upgrade
|
| EBITDA Margin | -20.77% | 14.05% | 16.97% | 15.81% | 10.00% | Upgrade
|
| D&A For EBITDA | 173.37 | 190.65 | 161.6 | 175.15 | 92.99 | Upgrade
|
| EBIT | -1,365 | 684.02 | 769.67 | 471.1 | 177.22 | Upgrade
|
| EBIT Margin | -23.79% | 10.98% | 14.02% | 11.52% | 6.56% | Upgrade
|
| Effective Tax Rate | - | - | - | 6.39% | 135.96% | Upgrade
|
| Revenue as Reported | 5,739 | 6,227 | 5,489 | 4,088 | 2,702 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.